[Brazilian Diabetes Society consensus statement--intensive insulin therapy and insulin pump therapy].
This article reports the Brazilian Diabetes Society consensus statement on intensive insulin therapy and insulin pump therapy, arrived at during an update symposium held in 2003 for this specific purpose. The concepts underlying these modalities of diabetes treatment are outlined, their fundaments are given, and practical issues about their indications, feasibility, limits, techniques and cost-benefit relationships are analyzed. The techniques comprise the suggested self-monitoring schedules and the insulin doses, types, forms of administration and correction factors used in each modality of intensive treatment, for both type 1 and 2 diabetes. The roles of SBD in the implementation of these treatments and of the different professionals involved are discussed and commented. The conclusions are based on consensual answers to some orienting questions formulated during the symposium's presentation.
Malerbi
Domingos
D
Sociedade Brasileira de Diabetes.
Damiani
Durval
D
Rassi
Nelson
N
Chacra
Antonio Roberto
AR
Niclewicz
Edgar D'Avila
ED
Silva Filho
Ruy Lyra da
RL
Dib
Sergio Atala
SA
D015190:Blood Glucose Self-Monitoring; D001938:Brazil; D003362:Cost-Benefit Analysis; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000191:economics; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D015918:Infusion Pumps, Implantable / Q000191:economics; D007328:Insulin / Q000008:administration & dosage*; D007332:Insulin Infusion Systems; D012955:Societies, Medical
D007004:Hypoglycemic Agents; D007328:Insulin